Skip to main content

Advertisement

Table 7 Cox multivariate analysis for OS

From: Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results

  Overall survival (OS)
HR (95% CI) p-value
DCR axitinib 0.336 (0.192–0.590) 0.00015
Performance status
 ECOG 0 1   0.058
 ECOG 1 0.872 (0.183–4.160) 0.863
 ECOG 2 1.706 (0.359–8.108) 0.502
Heng score
 Good 1   0.025
 Poor 3.426 (1.374–8.541) 0.008
 Intermediate 2.057 (1.040–4.068) 0.038
Nephrectomy
 Yes 0.319 (0.153–0.664) 0.002
Istology
 Clear cell carcinoma 0.402 (0.149–1.079) 0.070
Gender
 Male 0.629 (0.371–1.066) 0.085